Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Cahaya Mandiri Farma

02 1Swati Spentose

03 3Xian Wanlong Pharmaceutical Co. Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Dextran 70

About the Company : PT. Cahaya Mandiri Farma is a leading company in the pharmaceutical industry, dedicated to producing high-quality healthcare products for humans. We are committed to excellence thr...

PT. Cahaya Mandiri Farma is a leading company in the pharmaceutical industry, dedicated to producing high-quality healthcare products for humans. We are committed to excellence through the implementation of advanced technology and rigorous production standards that meet both national and international regulations. Our focus is on delivering innovative and reliable solutions to improve health and well-being, while maintaining the highest levels of safety and quality in every product we manufacture.
blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Dextran

About the Company : SWATI SPENTOSE PVT. LTD.(SSPL), a pharmaceutical company based in Mumbai, India having 2 manufacturing sites: SSPL Unit 1 and SSPL Unit 2. Please find attached a brief presentation...

SWATI SPENTOSE PVT. LTD.(SSPL), a pharmaceutical company based in Mumbai, India having 2 manufacturing sites: SSPL Unit 1 and SSPL Unit 2. Please find attached a brief presentation on our company. A USFDA inspected & WHO-GMP certified site, with 3 CEP’S as well as UK-MHRA, EDQM and TGA-Australia compliant API manufacture, specializing in manufacture of Polysaccharides.
blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Dextrans

About the Company : Xi'an Wanlong Pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates, GMP & ...

Xi'an Wanlong Pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates, GMP & DMF available. The company's registered capital reaches CNY 75 million. The building area of company is over 2,000,000 square meters. All the workshops are compliant with GMP requirements. There are more than 700 employees including over 100 RD staffs,20 experienced production management people and 8 senior professional registration specialists. Having a dynamic, high-quality team, which ensures our company sustainable and stable development.
blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Dextran 40

About the Company : Xi'an Wanlong Pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates, GMP & ...

Xi'an Wanlong Pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates, GMP & DMF available. The company's registered capital reaches CNY 75 million. The building area of company is over 2,000,000 square meters. All the workshops are compliant with GMP requirements. There are more than 700 employees including over 100 RD staffs,20 experienced production management people and 8 senior professional registration specialists. Having a dynamic, high-quality team, which ensures our company sustainable and stable development.
blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Dextran 70

About the Company : Xi'an Wanlong Pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates, GMP & ...

Xi'an Wanlong Pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates, GMP & DMF available. The company's registered capital reaches CNY 75 million. The building area of company is over 2,000,000 square meters. All the workshops are compliant with GMP requirements. There are more than 700 employees including over 100 RD staffs,20 experienced production management people and 8 senior professional registration specialists. Having a dynamic, high-quality team, which ensures our company sustainable and stable development.
blank

Dextran 70 Manufacturers | Traders | Suppliers

Dextran 70 Manufacturers, Traders, Suppliers 1
65

We have 3 companies offering Dextran 70

Get in contact with the supplier of your choice:

  1. Cahaya Mandiri Farma
  2. Swati Spentose
  3. Xian Wanlong Pharmaceutical Co. Ltd